Charles Faith L.
Related Filers (4)
- ABEONA THERAPEUTICS INC. (5)
- CNS Pharmaceuticals, Inc. (4)
- AVENUE THERAPEUTICS, INC. (2)
- CONDUIT PHARMACEUTICALS INC. (2)
- Show More ...
Ownership (13)
4
Tuesday, 12/5/2023
CONDUIT PHARMACEUTICALS INC.: Statement of changes in beneficial ownership of securities
4/A
Thursday, 10/12/2023
CNS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/29/2023
ABEONA THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/26/2023
CONDUIT PHARMACEUTICALS INC.: Initial statement of beneficial ownership of securities
4
Monday, 9/25/2023
CNS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
AVENUE THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2023
ABEONA THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/4/2023
CNS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/4/2023
CNS Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 9/28/2022
ABEONA THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
3
Tuesday, 5/17/2022
AVENUE THERAPEUTICS, INC.: Initial statement of beneficial ownership of securities
4
Thursday, 5/27/2021
ABEONA THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
3
Tuesday, 4/6/2021
ABEONA THERAPEUTICS INC.: Initial statement of beneficial ownership of securities